PHAXIAM Therapeutics S.A.
ERYP
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 6-K |
9/26/2023 |
Q2 |
2023 |
6/30/2023
|
SEC |
view |
|
| WIREPR |
5/9/2023 |
Q1 |
2023 |
3/31/2023
|
WIRE |
view |
data |
| 20-F |
3/28/2023 |
Q4 |
2022 |
12/31/2022
|
SEC |
view |
|
| WIREPR |
3/22/2023 |
Q4 |
2022 |
12/31/2022
|
WIRE |
view |
data |
| WIREPR |
9/12/2022 |
Q2 |
2022 |
6/30/2022
|
WIRE |
view |
data |
| 6-K/A |
9/12/2022 |
Q2 |
2022 |
6/30/2022
|
SEC |
view |
|
| 6-K |
9/12/2022 |
Q2 |
2022 |
6/30/2022
|
SEC |
view |
|
| 20-F |
4/27/2022 |
Q4 |
2021 |
12/31/2021
|
SEC |
view |
|
| WIREPR |
9/20/2021 |
Q2 |
2021 |
6/30/2021
|
WIRE |
view |
data |
| 6-K |
9/20/2021 |
Q2 |
2021 |
6/30/2021
|
SEC |
view |
|
| WIREPR |
5/4/2021 |
Q1 |
2021 |
3/31/2021
|
WIRE |
view |
data |
| WIREPR |
3/8/2021 |
Q4 |
2020 |
12/31/2020
|
WIRE |
view |
data |
| 20-F |
3/8/2021 |
Q4 |
2020 |
12/31/2020
|
SEC |
view |
|
| WIREPR |
11/5/2020 |
Q3 |
2020 |
9/30/2020
|
WIRE |
view |
data |
| WIREPR |
9/21/2020 |
Q2 |
2020 |
6/30/2020
|
WIRE |
view |
data |
| 6-K |
9/21/2020 |
Q2 |
2020 |
6/30/2020
|
SEC |
view |
|
| 20-F |
3/18/2020 |
Q4 |
2019 |
12/31/2019
|
SEC |
view |
|
| WIREPR |
3/16/2020 |
Q4 |
2019 |
12/31/2019
|
WIRE |
view |
data |
| WIREPR |
11/7/2019 |
Q4 |
2019 |
12/31/2019
|
WIRE |
view |
data |
| 6-K |
9/26/2019 |
Q2 |
2019 |
6/30/2019
|
SEC |
view |
|
| 20-F |
3/29/2019 |
Q4 |
2018 |
12/31/2018
|
SEC |
view |
|
| 20-F/A |
5/23/2018 |
Q4 |
2017 |
12/31/2017
|
SEC |
view |
|
| 20-F |
5/23/2018 |
Q4 |
2017 |
12/31/2017
|
SEC |
view |
|